MedTrace Logo

The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.

NCT05788133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2023-03-28

No results posted yet for this study

Summary

The role of humanoid robot in neuropsychological assessment and conducting cognitive training in patients with dementia and severe brain injury" Objectives Use of robotic solutions to carry out diagnostic and rehabilitation intervention in order to recover cognitive and relational performance of patients with dementia and severe brain injury.

Study Design. Observational Materials and Methods. Eighty subjects (25 with mild-moderate dementia and 25 patients with severe brain injury) will be enrolled. Patients will undergo neurological examination with collection of all medical history and information on current clinical condition. After that, they will undergo administration of neuropsychological tests via humanoid robot and two months of cognitive rehabilitation sessions.

Inclusion criteria

* Over 18 years of age;
* Patients with a moderately impaired cognitive profile;
* Written consent from the legal guardian or the patient himself/herself. Exclusion criteria.
* Patients with language comprehension deficits;
* Patients with disorders of consciousness;
* Patients who are unable to provide a localized, context-appropriate response; and All eligible patients will undergo cognitive assessment using the robot at the time of enrollment (T0), and after 2 months of rehabilitation treatment (T1)

Translated with www.DeepL.com/Translator (free version)

Conditions

Interventions

OTHER

treatment and screening by neuropsychological tests on humanoid robot

treatment and screening by neuropsychological tests on humanoid robot

Sponsors & Collaborators

  • IRCCS Centro Neurolesi Bonino Pulejo

    lead OTHER

Principal Investigators

  • silvia marino, MD · IRCCS Centro Neurolesi Bonino Pulejo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-28
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05788133 on ClinicalTrials.gov